CorMedix (CRMD) Earnings Date & Reports

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

CRMD is expected to report earnings to fall 29.55% to 15 cents per share on May 08

Q1'25

Est.

$0.16

Q4'24

Beat

by $0.05

Q3'24

Beat

by $0.06

Q2'24

Est.

$-0.25

Q1'24

Beat

by $0.01

The last earnings report on March 25 showed earnings per share of 21 cents, beating the estimate of 17 cents. With 1.22M shares outstanding, the current market capitalization sits at 400.87M.

View a ticker or compare two or three

Compare

CRMD